Cryo-Cell
Blood & Organ Banks · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
700 Brooker Creek Blvd Ste 1800, Oldsmar...Phone Number
(813) 749-2100Website
www.cryo-cell.comRevenue
$31.3 MillionStock Symbol
CCELIndustry
ZI Rank: 5
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
4
2
3
5
About Cryo-Cell
Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells Prepacyte CB units, a technology used to process umbilical cord blood stem cells. It stores approximately 300,000 cord blood and cord tissue specimens worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was founded in 1989 and is headquartered in OldsmarRead more
Cryo-Cell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cryo-Cell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Cryo-Cell, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Cryo-Cell recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Cryo-Cell launches new products
Check if Cryo-Cell has recently received funding, and reach out quickly before it becomes old news!
Check out if Cryo-Cell is spiking on competitors!
Click to see if Cryo-Cell had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Cryo-Cell has new funding data
Congratulate Masked Content for being promoted to Masked Content at Cryo-Cell
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Cryo-Cell
Compare insights from companies similar to Cryo-Cell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cryo-Cell is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Cryo-Cell is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Cryo-Cell.
Cryo-Cell Tech Stack
A closer look at the technologies used by Cryo-Cell
Most Recent Scoops
Person-Based
Earnings
Sales
Open Position
Cryo-Cell is currently seeking a Medical Director. (Durham, NC)
Earnings
Cryo-Cell has reported revenues of $8.10 million for Q3 FY 2020.
Earnings
Earnings
Cryo-Cell News & Media
Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced today that, as a result of the current economic environment and other capital allocation alternatives, its Board of Directors has approved the payment of a reduced, quarterly cash dividend of $0.15 per share of common stock to be paid to its shareholders of record as of the closeCord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2025. Financial Results Revenue The revenues for the first quarter of fiscal 2025 were $7.97 million compared to $7.85 million for the first quarter of fiscal 2024. The revenues for the first quarter of fiscal 2025 consisted ofCryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2024. Financial Results Revenue Consolidated revenues for fiscal 2024 were $32.0 million compared to $31.3 million for fiscal 2023. The revenues for fiscal 2024 consisted of $31.6 million in processing and storage fee revenue, $68,000 in product revenueCord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced today that its Board of Directors has approved the payment of a quarterly cash dividend of $0.25 per share of common stock to be paid to its shareholders of record as of the close of business on February 14, 2025. The dividend is expected to be paid on
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cryo-Cell
Sign Up For FreeTo access detailed company insights
Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to... Read More
